dihydroxyphenylalanine and salicylates

dihydroxyphenylalanine has been researched along with salicylates in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koppenol, WH; Maskos, Z; Rush, JD1
Almeyda, J; Levantine, A1
Eller, PM; Finelli, VN; Montague, PJ; Petering, HG1
Altschule, MD; Hegedus, ZL1
Jacobsen, CD1
d'Ischia, M; Memoli, S; Napolitano, A; Nappi, AJ; Prota, G1
PRZIC, R; STERN, P1

Reviews

1 review(s) available for dihydroxyphenylalanine and salicylates

ArticleYear
Drug reactions. 23. Drug induced alopecia.
    The British journal of dermatology, 1973, Volume: 89, Issue:5

    Topics: Alopecia; Amphetamine; Anticholesteremic Agents; Anticoagulants; Anticonvulsants; Antineoplastic Agents; Antithyroid Agents; Contraceptives, Oral; Cystine; Dihydroxyphenylalanine; Female; Gentamicins; Hair; Humans; Middle Aged; Salicylates; Thallium; Vitamin A

1973

Other Studies

6 other study(ies) available for dihydroxyphenylalanine and salicylates

ArticleYear
The hydroxylation of phenylalanine and tyrosine: a comparison with salicylate and tryptophan.
    Archives of biochemistry and biophysics, 1992, Aug-01, Volume: 296, Issue:2

    Topics: Chelating Agents; Dihydroxyphenylalanine; Gamma Rays; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxides; Hydroxyl Radical; Hydroxylation; Iron; Kinetics; Macromolecular Substances; Oxidation-Reduction; Phenylalanine; Pulse Radiolysis; Salicylates; Salicylic Acid; Tryptophan; Tyrosine

1992
Potent in vitro inhibitors of tyrosinase: metal-binding fractions of tobacco smoke condensate.
    Toxicology and applied pharmacology, 1974, Volume: 27, Issue:2

    Topics: Basidiomycota; Catechol Oxidase; Copper; Cyanides; Cysteine; Dihydroxyphenylalanine; Kinetics; Metals; Nicotiana; Phenanthrolines; Plants, Toxic; Quinolines; Salicylates; Smoke; Thiocarbamates; Tyrosine

1974
Orthohydroxyhippuric (salicyluric) acid--its physiologic and clinical significance.
    Clinical pharmacology and therapeutics, 1974, Volume: 15, Issue:2

    Topics: Anemia; Animals; Cattle; Dihydroxyphenylalanine; Dogs; Down Syndrome; Fever; Glycine; Humans; Hypertension; Liver Diseases; Methyldopa; Mitochondria, Liver; Pheochromocytoma; Rats; Salicylates; Swine; Uremia; Wounds and Injuries

1974
[Drug-induced anemias].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1970, Dec-15, Volume: 90, Issue:24

    Topics: Adrenal Cortex Hormones; Anemia; Barbiturates; Bone Marrow; Chloramphenicol; Chlorpromazine; Dihydroxyphenylalanine; Gastrointestinal Hemorrhage; Gold; Humans; Hypoglycemic Agents; Indomethacin; Isoniazid; Nitrofurantoin; Phenacetin; Phenylbutazone; Phenytoin; Quinidine; Quinine; Salicylates; Sulfonamides

1970
5-S-cysteinyldopa, a diffusible product of melanocyte activity, is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system.
    Biochimica et biophysica acta, 1996, Aug-29, Volume: 1291, Issue:1

    Topics: Aerobiosis; Anaerobiosis; Borohydrides; Chelating Agents; Cysteinyldopa; Dihydroxyphenylalanine; Edetic Acid; Free Radical Scavengers; Hydrogen Peroxide; Hydroxylation; Iron Chelating Agents; Melanocytes; Oxidation-Reduction; Salicylates; Salicylic Acid

1996
A contribution to the therapy of the intentional tremor.
    Life sciences (1962), 1962, Volume: 1

    Topics: Dihydroxyphenylalanine; Humans; Hydralazine; Salicylates; Tremor

1962